Edesa Biotech Inc (EDSA) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Edesa Biotech Inc   (NASDAQ: EDSA)


Edesa Biotech Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Edesa Biotech Inc's ROI in the third quarter of 2026?
Edesa Biotech Inc recorded a cumulative net loss of $-14 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -127.69%.

Within the Healthcare sector 658 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3281 to 3977.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Investment Change TTM 30.36 % 118.8 % 380.79 % 167.24 % 55.48 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 9 10 13 13 14
Return On Investment (TTM) -127.69 % -84.4 % -57.01 % -64.79 % -69.87 %
EDSA's Overall Ranking # 3977 # 3281 # 3243 # 3522 # 3176
Seq. Investment Change TTM -10.75 % -9.74 % 23.61 % 30.91 % 49.8 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -14 -10 -8 -7 -6

EDSA Company Profile >> Back to EDSA Roi Comparisons >> See Annual EDSA Return On Investment



Return On Investment EDSA's Ranking
Within: No.
Industry # 295
Sector # 659
Overall # 3977

Return On Investment Statistics
High Average Low
14.89 %
-87.86 %
-214.24 %
(Sep 30 2019)   (Dec 31 2024)







Financial Statements
Edesa Biotech Inc's III. Quarter Investments $ 9 Millions EDSA's Balance sheet
Edesa Biotech Inc's III. Quarter Income $ -5 Millions Quarterly EDSA's Income Statement
EDSA's Income by Division See EDSA's Income by Division


EDSA Annual Return On Investment (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021
Total Investments in Millions 13 2 7 9 13
Y / Y Investment Growth 497.16 % -71.14 % -22.91 % -28.34 % 92.74 %
Net Income in Millions -7 -6 8 18 13
Y / Y Net Income Growth - - -52.28 % 31.52 % -
Annual Return On Investment -57.11 % -292.81 % 114.69 % 185.29 % 100.95 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EDSA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EDSA's Competitors
Subscribers only: Roi for Edesa Biotech Inc's Suppliers
Subscribers only: Return On Investment for EDSA's Customers

Other Ratios
EDSA's Roa EDSA's Inventory Turnover Ratio EDSA's Growth Rates EDSA's Dividend Statistics
EDSA's Profitability Ratios EDSA's Asset Turnover Ratio EDSA's Dividend Growth
EDSA's Roe EDSA's Valuation Ratios EDSA's Financial Strength Ratios EDSA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-03T11:43:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.